Market Timing with TurnerTrends Provides Great Stock Picks for the Sophisticated Investor   Timing the Market well requires Stock Picks that work

TurnerTrends Stock Rating Report for CLDA

Data valid for week beginning July 21, 2008

Ticker Company Name
CLDA   [News] Clinical Data Inc
Company Profile
"Clinical Data, Inc. provides molecular and pharmacogenomics services, as well as clinical diagnostics for the improvement of patient care worldwide. It has two divisions, PGxHealth and Cogenics. The PGxHealth division focuses on biomarkers and related test development, validation, and commercialization activities designed to improve the efficacy and safety of drugs for patients. It markets these genetic tests to providers, payers, and consumers. This division is also seeking to develop and commercialize Vilazodone, a novel dual-serotonergic antidepressant compound being studied for the treatment of depression along with a potential companion pharmacogenetic test. The Cogenics division offers a range of genomics services for both research and regulated projects, including services to support pharmacogenomics discovery and validation, and biomarker research and development. Its services include sequencing, genotyping, gene expression, and bio-banking in both regulated and unregulated markets for pharmaceutical, biotechnology, academic, agricultural, and government clients. The company was founded in 1969 and is headquartered in Newton, Massachusetts."

Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.

CLDA Technical Chart

We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for CLDA. However, we only show it to our subscribers.

We update our ratings and stop losses EVERY WEEK.

Don't miss out on what we recommend for Clinical Data Inc next week. Sign up today and start making money!

FREE TRIAL!!


Stock Information
Friday's Close $14.31
Volume Avg. 154241 shares
Industry Biotechnology
Sector Healthcare
Our Stop Loss Members Only
Expected Move Members Only
Optionable? Yes

Want to take a more "hands off" approach to investing with TurnerTrends? Try our managed accounts and hedge fund at Sabinal Capital Investments
Stock Financials
Profit Margin -103.81%
Operating Margin -141.64%
Debt-to-Equity .07%
P/E ttm 0.00
EPS ttm $-1.850
EBITDA $-41,600,000
Total Revenue $34,030,000
Market Cap $290,660
Annual Dividend $.00
Yield .000%
ROE -58.83%
Revenue Growth Rate Quarterly 10.30%
Earnings Growth Rate Quarterly 0.00%
Earnings Growth Rate Yearly 0.00%
Revenue Growth Rate Average 16.48%
Earnings Growth Rate Average 0.00%
Institutional Ownership Members Only
Value Rating Members Only
TurnerTrends Score Members Only


Latest News

Tue, 15 Jul 2008 10:30:00 Etc/GMTClinical Data's Cogenics Division to Provide Global Genotyping Solutions for Lundbeck's Clinical Studies (Business Wire)
Thu, 10 Jul 2008 19:15:00 Etc/GMTWall Street Media Presents Exclusive Videos from the Collins Stewart Fourth Annual Growth Conference and the T. Boone Pickens Press Conference (Business Wire)
Wed, 9 Jul 2008 13:12:05 Etc/GMTCLINICAL DATA INC Files SEC form 8-K, Regulation FD Disclosure (EDGAR Online)
Mon, 7 Jul 2008 17:40:00 Etc/GMTClinical Data to Present at Collins Stewart 4th Annual Growth Conference in New York (Business Wire)
Mon, 30 Jun 2008 18:16:09 Etc/GMTRussell 2000 adds 53 health care companies (AP)
Mon, 30 Jun 2008 10:30:00 Etc/GMTClinical Data, Inc. Included in Russell 3000(R) Index (Business Wire)
Thu, 26 Jun 2008 10:30:00 Etc/GMTClinical Data Secures EU Patent for MDR1 - A Key Multi-Drug Resistance Gene (Business Wire)
Tue, 24 Jun 2008 19:52:54 Etc/GMTClinical Data director buys stock (AP)
Fri, 20 Jun 2008 10:30:00 Etc/GMTClinical Data's Cogenics Division and NIEHS Researchers Confirm Utility of Blood Samples for Gene Expression Analysis of Drug-Induced Liver Injury (Business Wire)
Tue, 17 Jun 2008 13:22:40 Etc/GMTNew Star Analyst Rankings for CLINICAL DATA INC (StarMine)
Mon, 16 Jun 2008 11:58:23 Etc/GMTCLINICAL DATA INC Files SEC form 8-K, Results of Operations and Financial Condition (EDGAR Online)
Mon, 16 Jun 2008 10:30:00 Etc/GMTClinical Data Reports Strong Fourth Quarter and Fiscal Year 2008 Results (Business Wire)
Tue, 3 Jun 2008 10:30:00 Etc/GMTCogenics, Roche's 454 Life Sciences and Limagrain to Jointly Develop Solutions for Crop SNP Discovery With Next Generation Sequencing (Business Wire)
Thu, 29 May 2008 10:30:00 Etc/GMTClinical Data's Cogenics Division Completes Installation of Illumina iScan System (Business Wire)
Thu, 15 May 2008 18:48:05 Etc/GMT[video] Towards Personalized Medicine [1.0 min] (at MarketWatch)
Thu, 15 May 2008 13:52:05 Etc/GMTCorrection: May 14 Clinical Data Inc. testing story (AP)
Wed, 14 May 2008 20:32:08 Etc/GMTClinical Data Inc. adds test for heart condition (AP)
Wed, 14 May 2008 10:30:00 Etc/GMTClinical Data Launches Genetic Test For Hypertrophic Cardiomyopathy (HCM) (Business Wire)
Fri, 9 May 2008 10:30:00 Etc/GMTClinical Data's FAMILION(R) Family of Tests to be Highlighted by Two Presentations at Heart Rhythm 2008 (Business Wire)
Thu, 8 May 2008 15:27:45 Etc/GMTCLINICAL DATA INC Files SEC form 8-K, Regulation FD Disclosure (EDGAR Online)
News provided by Yahoo! Finance